Chelsea and Westminster Hospital pioneers autonomous artificial intelligence (AI) pathway for skin cancer to discharge harmless cases
Posted:
Chelsea and Westminster Hospital NHS Foundation Trust is utilising digital innovation and world-first autonomous technology to identify harmless (benign) skin lesions without review from the dermatology team, to be able to discharge patients on the same day as they receive their results.
This advanced AI skin cancer pathway helps clinicians and dermatologists effectively triage patients, enabling earlier detection.
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
This guidance is divided into sections on the different rules that apply in Great Britain, Northern Ireland and the…
Calling innovators in these spaces:
Advanced Manufacturing
Clean Energy Industries
Creative Industries
Defence
Digital and Technologies
Life Sciences
Medical Technologies Innovation Facility (MTIF) is looking for collaborators for the UKRI Innovate UK Advanced manufacturing supply chain innovation challenge.
Read more…
Attendees
Sponsors and Exhibitors
Contact us